Our Pipeline

Utilizing Our Proprietary Technologies to Create Life-Changing Therapies

Internal Development Programs

Program Indication Preclinical Phase 1 Phase 2 Phase 3 Next Catalyst
XCART Platform B-Cell Non-Hodgkin Lymphoma
Preclinical Phase in progress
Phase 1 Phase not started
Phase 2 Phase not started
Phase 3 Phase not started
Meet with regulatory authorities to discuss development plan
PolyXen™ Next Generation Delivery Platform for Biologics Potential for non-dilutive milestone and royalty payments from partners